Over a decade ago,
James Baurley, PhD, a software engineer by trade, and mathematician
Carolyn Ervin, PhD, founded BioRealm, a genomic and artificial intelligence
solutions provider that is helping researchers at institutions like
the United States National Institute on Drug Abuse (NIDA) identify,
on a large scale, genetic variants that can be linked to addiction.
The company’s flagship product, Smokescreen, is being used by
clinical researchers and healthcare providers to...